Julia Blievernicht

Statistics

Publications

Citations

1.7K

H-Index

Active since

2006

Affiliations

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(Current)

University of Tübingen

Indiana University – Purdue University Indianapolis

Julia Blievernicht is an author at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology specializing in pharmacology, pharmacogenetics, and medicine.

Publications per year

2006–2015

Publications

Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group

Matthias Schwab, Ulrich M. Zanger, Claudia Marx et al. · Journal of Clinical Oncology · 2008 · 394 citations · Full text

Pharmacy, Genetics, Oncology +17

Polymorphic<i>CYP2B6</i>: Molecular Mechanisms and Emerging Clinical Significance

Ulrich M. Zanger, Kathrin Klein, Julia Blievernicht et al. · Pharmacogenomics · 2007 · 259 citations

Medicine, Pharmacokinetics, Pharmacology +15

Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV-infected Individuals

Margalida Rotger, Heike Tegude, Sara Colombo et al. · Clinical Pharmacology & Therapeutics · 2007 · 256 citations

Medicine, Pharmacokinetics, Pharmacology +17

Impact of CYP2B6 Polymorphism on Hepatic Efavirenz Metabolism<i>in Vitro</i>

Zeruesenay Desta, Bryan A. Ward, Julia Blievernicht et al. · Pharmacogenomics · 2007 · 224 citations

Medicine, Pharmacokinetics, Pharmacology +15

Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver

Marco H. Hofmann, Julia Blievernicht, Kathrin Klein et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 213 citations

Medicine, Molecular Genetics, Pharmacology +16

1–5 of 10